financetom
Business
financetom
/
Business
/
ODDITY Tech beats Q2 adjusted profit  estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ODDITY Tech beats Q2 adjusted profit  estimates
Aug 4, 2025 1:41 PM

Overview

* ODDITY Tech ( ODD ) Q2 revenue rises 25% yr/yr, beating analyst expectations, per LSEG data

* Adjusted EPS for Q2 beats consensus, per LSEG data

* Co plans Brand 3 launch, expanding into medical-grade products

Outlook

* ODDITY raises FY2025 revenue outlook to $799-804 mln

* Company expects FY2025 adjusted EBITDA of $160-162 mln

* ODDITY forecasts Q3 revenue between $144 mln and $146 mln

* Company sees FY2025 adjusted EPS between $2.06 and $2.09

Result Drivers

* ONLINE REVENUE GROWTH - Double-digit online revenue growth for IL MAKIAGE and SpoiledChild contributed to Q2 results

* INTERNATIONAL EXPANSION - Accelerated international expansion supported revenue growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Beat $241 mln $238.40

Revenue mln (6

Analysts

)

Q2 Beat $0.92 $0.88 (7

Adjusted Analysts

EPS )

Q2 EPS $0.79

Q2 Beat $57 mln $52.90

Adjusted mln (5

Net Analysts

Income )

Q2 Beat $70 mln $67.30

Adjusted mln (5

EBITDA Analysts

)

Q2 Gross 72.3%

Margin

Q2 28.8%

Adjusted

EBITDA

Margin

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the personal products peer group is "buy"

* Wall Street's median 12-month price target for Oddity Tech Ltd ( ODD ) is $72.50, about 1.1% above its August 1 closing price of $71.70

* The stock recently traded at 32 times the next 12-month earnings vs. a P/E of 29 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hercules Capital Insider Sold Shares Worth $1,958,640, According to a Recent SEC Filing
Hercules Capital Insider Sold Shares Worth $1,958,640, According to a Recent SEC Filing
Oct 3, 2024
03:08 AM EDT, 09/30/2024 (MT Newswires) -- Scott Bluestein, Chief Executive Officer, on September 26, 2024, sold 100,000 shares in Hercules Capital ( HTGC ) for $1,958,640. Following the Form 4 filing with the SEC, Bluestein has control over a total of 2,161,207 shares of the company, with 2,161,207 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1280784/000156218024006976/xslF345X05/primarydocument.xml Price: 19.82, Change: +0.07, Percent...
Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression
Alnylam Pharmaceuticals Says Investigational Drug Slowed ATTR Amyloidosis Progression
Oct 3, 2024
03:53 AM EDT, 09/30/2024 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said Sunday two sets of data from a phase 3 study showed that its vutrisiran investigational drug for treatment for ATTR amyloidosis with cardiomyopathy slowed disease progression. The illness causes a gradual thickening of the cardiac wall and a deterioration in heart functions leading to possible cardiac stress....
Fortress Biotech Files Registration Statement on Behalf of Selling Shareholders
Fortress Biotech Files Registration Statement on Behalf of Selling Shareholders
Oct 3, 2024
04:13 AM EDT, 09/30/2024 (MT Newswires) -- Fortress Biotech ( FBIO ) on Friday filed a registration statement for the offering of up to about 6.2 million shares of its common stock by certain selling shareholders. The prospectus covers the sale from time to time of shares of outstanding common shares and shares issuable upon warrant exercises. The company will...
DraftKings Insider Sold Shares Worth $26,545,315, According to a Recent SEC Filing
DraftKings Insider Sold Shares Worth $26,545,315, According to a Recent SEC Filing
Oct 3, 2024
03:11 AM EDT, 09/30/2024 (MT Newswires) -- Paul Liberman, Director, President, Global Technology and Product, on September 25, 2024, sold 643,654 shares in DraftKings ( DKNG ) for $26,545,315. Following the Form 4 filing with the SEC, Liberman has control over a total of 572,543 shares of the company, with 21,638 shares held directly and 550,905 controlled indirectly. SEC Filing:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved